In CRC, METTL3-mediated m6A modification of GLUT1 mRNA enhances its translational efficiency, leading to increased glucose uptake, lactate production, and mTORC1 signaling activation, thereby driving tumor growth [112]. This evidence concerns the gene METTL3 and colorectal carcinoma.